{
    "id": 11666,
    "fullName": "PTCH1 del",
    "impact": "deletion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "PTCH1 del indicates a deletion of the PTCH1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5727,
        "geneSymbol": "PTCH1",
        "terms": [
            "PTCH1",
            "BCNS",
            "NBCCS",
            "PTC",
            "PTC1",
            "PTCH"
        ]
    },
    "variant": "del",
    "createDate": "09/10/2015",
    "updateDate": "05/01/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5604,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Glabrescione B inhibited proliferation of a mouse basal cell carcinoma cell line harboring a Ptch1 deletion in culture, and inhibited tumor growth in allograft models (PMID: 25476449).",
            "molecularProfile": {
                "id": 11725,
                "profileName": "PTCH1 del"
            },
            "therapy": {
                "id": 3904,
                "therapyName": "Glabrescione B",
                "synonyms": null
            },
            "indication": {
                "id": 2513,
                "name": "basal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2682,
                    "pubMedId": 25476449,
                    "title": "Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25476449"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6319,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Posaconazole inhibited Hedghog signaling in PTCH1-deleted mouse fibroblasts in culture (PMID: 26823493).",
            "molecularProfile": {
                "id": 11725,
                "profileName": "PTCH1 del"
            },
            "therapy": {
                "id": 4108,
                "therapyName": "Posaconazole",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5515,
                    "pubMedId": 26823493,
                    "title": "Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26823493"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11725,
            "profileName": "PTCH1 del",
            "profileTreatmentApproaches": [
                {
                    "id": 7725,
                    "name": "SMO Inhibitor",
                    "profileName": "PTCH1 del"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}